BioPharma Dive 2025-12-22 Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
BioPharma Dive 2025-12-22 Trump to test ‘most favored nation’ pricing for Medicare; Shionogi pays $2.5B for ALS drug
BioPharma Dive 2025-12-18 Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial
BioPharma Dive 2025-12-18 Insmed’s ‘win streak’ ends as top drug fails study in chronic nasal condition
BioPharma Dive 2025-12-18 Orum, a biotech marrying ADCs with protein degraders, captures $100M in funding
BioPharma Dive 2025-12-17 Peanut allergy patch succeeds in late-stage study 5 years after FDA rejection
BioPharma Dive 2025-12-17 Addition emerges with $100M to make gene therapies for chronic and rare diseases
BioPharma Dive 2025-12-16 Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study